AbbVie | ABBV - Srodki Pieniężne I Ekwiwalent

Cena Akcji
227.45
Dzienna Zmiana
-2.66 -1.16%
Miesięcznie
2.25%
Rocznie
4.98%
Q1 Prognozy TE
223.16




Srodki Pieniężne I Ekwiwalent Zmiana Data
AbbVie USD 5.23B 400M 2025-12
Abbott USD 8.52B 1.01B 2025-12
ALKERMES USD 388.57M 227.88M 2025-12
Amgen USD 9.13B 316M 2025-12
AstraZeneca USD 8.14B 1.08B 2025-09
Biogen USD 3.01B 854.3M 2025-12
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Coherus Biosciences USD 88.88M 14.47M 2025-12
Eisai JPY 301.65B 16.27B 2025-09
Eli Lilly USD 7.27B 2.52B 2025-12
Gilead Sciences USD 7.33B 2.19B 2025-09
GlaxoSmithKline GBP 3.3B 303M 2025-09
Infinity Pharmaceuticals USD 17.75M 7.99M 2023-06
J&J USD 19.71B 1.48B 2025-12
Medtronic USD 1.28B 9M 2025-09
Merck USD 18.17B 10.16B 2025-09
Neurocrine Biosciences USD 713M 372.8M 2025-12
Novartis USD 9.56B 2.9B 2025-09
Pacira USD 158.54M 10.96M 2025-12
Perrigo USD 432.1M 22.1M 2025-09
Pfizer USD 1.34B 295M 2025-09
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
UCB EUR 1.57B 1.14B 2024-12
Ultragenyx Pharmaceutical USD 202.51M 36.4M 2025-09
United Therapeutics USD 1.56B 217M 2025-12
Vertex Pharmaceuticals USD 6.61B 321.1M 2025-12
Zoetis USD 2.08B 649M 2025-09